Cite
HARVARD Citation
Trouiller, J. et al. (2022). Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial. BMJ open. 12 (11), p. . [Online].